NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 14 2025
0mins
Source: Globenewswire
Company Name Change and Focus: INVO Fertility, Inc., previously known as NAYA Biosciences, is refocusing on the fertility market by establishing and operating fertility clinics and distributing the FDA-cleared INVOcell device, following a strategic separation from its oncology operations.
NAYA Therapeutics Transition: The subsidiary NAYA Therapeutics will operate as a private company concentrating on the clinical development of bifunctional antibodies, while INVO Fertility aims to leverage existing operations to expand its presence in the U.S. fertility market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
